GPCR

Structure Therapeutics (GPCR)

About Structure Therapeutics (GPCR)

Structure Therapeutics, Inc. is a clinical stage global biopharmaceutical company, which engages in developing novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its pipeline includes Aleniglipron GSBR-1290, ACCG-2671, GIPR, GCGR, ANPA-0073, and LTSE-2578. The company was founded by Raymond C. Stevens in 2016 and is headquartered in South San Francisco, CA.

Details

Daily high

$48.67

Daily low

$46.75

Price at open

52 Week High

$94.90

52 Week Low

$13.22

Market cap

3.3B

Dividend yield

0.00%

Volume

900

Avg. volume

960,718

P/E ratio

-19.14

Structure Therapeutics News